Skip to main content
Top
Literature
2.
go back to reference Ni J, Wu GD, Albenberg L, Tomov VT. Gut microbiota and IBD: causation or correlation? HHS public access. Nat Rev Gastroenterol Hepatol. 2017;14:573–584.CrossRefPubMedPubMedCentral Ni J, Wu GD, Albenberg L, Tomov VT. Gut microbiota and IBD: causation or correlation? HHS public access. Nat Rev Gastroenterol Hepatol. 2017;14:573–584.CrossRefPubMedPubMedCentral
4.
go back to reference Teunis PFM, Sukhrie FHA, Vennema H, Bogerman J, Beersma MFC, Koopmans MPG. Shedding of norovirus in symptomatic and asymptomatic infections. Epidemiol Infect. 2015;143:1710–1717.CrossRefPubMed Teunis PFM, Sukhrie FHA, Vennema H, Bogerman J, Beersma MFC, Koopmans MPG. Shedding of norovirus in symptomatic and asymptomatic infections. Epidemiol Infect. 2015;143:1710–1717.CrossRefPubMed
5.
go back to reference Freeman K, Mistry H, Tsertsvadze A, et al. Multiplex tests to identify gastrointestinal bacteria, viruses and parasites in people with suspected infectious gastroenteritis: a systematic review and economic analysis. Health Technol Assess (Rockv). 2017;21:1–188.CrossRef Freeman K, Mistry H, Tsertsvadze A, et al. Multiplex tests to identify gastrointestinal bacteria, viruses and parasites in people with suspected infectious gastroenteritis: a systematic review and economic analysis. Health Technol Assess (Rockv). 2017;21:1–188.CrossRef
7.
go back to reference Johnson J, Affolter K, Boynton K, Chen X, Valentine J, Peterson K. CMV Disease in IBD: comparison of diagnostic tests and correlation with disease outcome. Inflamm Bowel Dis. 2018;24:1539–1546.CrossRefPubMed Johnson J, Affolter K, Boynton K, Chen X, Valentine J, Peterson K. CMV Disease in IBD: comparison of diagnostic tests and correlation with disease outcome. Inflamm Bowel Dis. 2018;24:1539–1546.CrossRefPubMed
8.
go back to reference Thörn M, Rorsman F, Rönnblom A, et al. Active cytomegalovirus infection diagnosed by real-time PCR in patients with inflammatory bowel disease: a prospective, controlled observational study. Scand J Gastroenterol. 2016;51:1075–1080.CrossRefPubMed Thörn M, Rorsman F, Rönnblom A, et al. Active cytomegalovirus infection diagnosed by real-time PCR in patients with inflammatory bowel disease: a prospective, controlled observational study. Scand J Gastroenterol. 2016;51:1075–1080.CrossRefPubMed
9.
go back to reference Neumann H, Vieth M, Atreya R, et al. Assessment of Crohn’s disease activity by confocal laser endomicroscopy. Inflamm Bowel Dis. 2012;18:2261–2269.CrossRefPubMed Neumann H, Vieth M, Atreya R, et al. Assessment of Crohn’s disease activity by confocal laser endomicroscopy. Inflamm Bowel Dis. 2012;18:2261–2269.CrossRefPubMed
10.
go back to reference Kiesslich R, Duckworth CA, Moussata D, et al. Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease. Gut. 2012;61:1146–1153.CrossRefPubMed Kiesslich R, Duckworth CA, Moussata D, et al. Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease. Gut. 2012;61:1146–1153.CrossRefPubMed
11.
go back to reference Rasmussen DN, Karstensen JG, Riis LB, Brynskov J, Vilmann P. Confocal laser endomicroscopy in inflammatory bowel disease—a systematic review. J Crohn’s Colitis. 2015;9:1152–1159.CrossRef Rasmussen DN, Karstensen JG, Riis LB, Brynskov J, Vilmann P. Confocal laser endomicroscopy in inflammatory bowel disease—a systematic review. J Crohn’s Colitis. 2015;9:1152–1159.CrossRef
12.
go back to reference Neumann H, Günther C, Vieth M, et al. Confocal laser endomicroscopy for in vivo diagnosis of clostridium difficile associated colitis—a pilot study. PLoS ONE. 2013;8:1–7. Neumann H, Günther C, Vieth M, et al. Confocal laser endomicroscopy for in vivo diagnosis of clostridium difficile associated colitis—a pilot study. PLoS ONE. 2013;8:1–7.
13.
go back to reference Leal SM, Popowitch EB, Levinson KJ, et al. Quantitative thresholds enable accurate identification of clostridium difficile infection by the Luminex xTAG gastrointestinal pathogen panel. J Clin Microbiol. 2018;56:e01885-17.CrossRefPubMedPubMedCentral Leal SM, Popowitch EB, Levinson KJ, et al. Quantitative thresholds enable accurate identification of clostridium difficile infection by the Luminex xTAG gastrointestinal pathogen panel. J Clin Microbiol. 2018;56:e01885-17.CrossRefPubMedPubMedCentral
14.
go back to reference Khanna S, Shin A, Kelly CP. Management of clostridium difficile infection in inflammatory bowel disease: expert review from the clinical practice updates committee of the AGA institute. Clin Gastroenterol Hepatol. 2017;15:166–174.CrossRefPubMed Khanna S, Shin A, Kelly CP. Management of clostridium difficile infection in inflammatory bowel disease: expert review from the clinical practice updates committee of the AGA institute. Clin Gastroenterol Hepatol. 2017;15:166–174.CrossRefPubMed
Metadata
Title
Current Aspects on Differentiating Relapses from Over-Infections in Symptomatic Inflammatory Bowel Diseases
Authors
Christos Liatsos
Apostolis Papaefthymiou
Maria Tzouvala
Michael Doulberis
Evangelia Petridou
Jannis Kountouras
Publication date
01-09-2019
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2019
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-05755-8

Other articles of this Issue 9/2019

Digestive Diseases and Sciences 9/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.